相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Selective tissue targeting of synthetic nucleic acid drugs
Punit P. Seth et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The valency of fatty acid conjugates impacts siRNA pharmacokinetics, distribution, and efficacy in vivo
Annabelle Biscans et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
Thazha P. Prakash et al.
NUCLEIC ACIDS RESEARCH (2019)
Lipid Conjugates Enhance Endosomal Release of Antisense Oligonucleotides Into Cells
Shiyu Wang et al.
NUCLEIC ACID THERAPEUTICS (2019)
Hydrophobicity drives the systemic distribution of lipid-conjugated siRNAs via lipid transport pathways
Maire F. Osborn et al.
NUCLEIC ACIDS RESEARCH (2019)
Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay
Hans J. Gaus et al.
NUCLEIC ACIDS RESEARCH (2019)
Lymphatic System Flows
James E. Moore et al.
ANNUAL REVIEW OF FLUID MECHANICS, VOL 50 (2018)
Targeted delivery of antisense oligonucleotides to pancreatic β-cells
C. Ammala et al.
SCIENCE ADVANCES (2018)
Visualization of self-delivering hydrophobically modified siRNA cellular internalization
Socheata Ly et al.
NUCLEIC ACIDS RESEARCH (2017)
Distribution of FcRn Across Species and Tissues
Sari Latvala et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2017)
Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury
Michal Pyzik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice
Dominic Jauvin et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Comprehensive Structure-Activity Relationship of Triantennary N-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to Hepatocytes
Thazha P. Prakash et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
Richard S. Geary et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin
Michal Pyzik et al.
JOURNAL OF IMMUNOLOGY (2015)
Albumin-deficient mouse models for studying metabolism of human albumin and pharmacokinetics of albumin-based drugs
Derry C. Roopenian et al.
MABS (2015)
Identification and Characterization of Modified Antisense Oligonucleotides Targeting DMPK in Mice and Nonhuman Primates for the Treatment of Myotonic Dystrophy Type 1
Sanjay K. Pandey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Unraveling the mysteries of serum albumin-more than just a serum protein
Angelica M. Merlot et al.
FRONTIERS IN PHYSIOLOGY (2014)
Caveolae-Dependent and -Independent Uptake of Albumin in Cultured Rodent Pulmonary Endothelial Cells
Hui-Hua Li et al.
PLOS ONE (2013)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs
DC Roopenian et al.
JOURNAL OF IMMUNOLOGY (2003)
The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan
C Chaudhury et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer
TA John et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice - Treatment with a specific nitric-oxide synthase inhibitor, L-name, restores normal microvascular permeability in Cav-1 null mice
W Schubert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo
W Schubert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice
M Drab et al.
SCIENCE (2001)